Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 5Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Hematologic Neoplasms 1Blast Crisis 1

Interventions

Cyclophosphamide 17fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 15Busulfan 15Tacrolimus 13Methotrexate 13Antilymphocyte Serum 12Mycophenolic Acid 11Cyclosporine 11Whole-Body Irradiation 8Flow Cytometry 8Radiotherapy 6Methylprednisolone 6Melphalan 6Filgrastim 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Etoposide 5thymoglobulin 4Polymerase Chain Reaction 4Immunoenzyme Techniques 4Sirolimus 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Aprepitant 3Alemtuzumab 3Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Neutrophilic, Chronic × fedratinib × Clear all
NCT05177211 2026-04-17

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
25 enrolled 13 charts
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Neutrophilic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡